Reviticell Holdings

About Reviticell Holdings

Reviticell Kits are highly scalable medical devices that will make regenerative medical procedures efficient. Efficiency increases productivity and reduces costs which result in greater profitability for doctors and increased affordability for patients. The current lack of standardization in the industry has led to inefficient methods and inconsistent patient outcomes. A Reviticell Kit will significantly improve upon the status quo by optimizing and standardizing procedures so that any medical professional can conduct a given protocol in the exact same way - like a paint-by-numbers system - thereby minimizing patient risk and limiting doctor liability. A Reviticell Kit’s proprietary platform technology is an essential tool for the regenerative medicine industry because it will meet the unmet need for a standardized system that makes it possible for doctors to perform regenerative medical procedures in a way that is safe, predictable and consistent. The unique correlation of technology and components in Reviticell Kits will result in multiple revenue streams that continue to increase in number and magnitude as medical technologies advance. Regenerative medicine is an industry focused on revolutionary procedures that utilize a patient’s blood or body fat to restore parts of their body that have been damaged by trauma, disease or congenital defects. Locked within body fat are stem cells – the building blocks of their bodies. Unlocking these powerful cells is the key to the future of Regenerative Medicine and Reviticell Kits will be the means to facilitate their release. EquityNet’s patented algorithms rank Reviticell at 170% of the potential reward but at only 23% of the risk as compared to their peer group. You can invest in Reviticell at $1.00 per share and a minimum of $10,000. Click Request Plan to see their Business Plan or contact us at [email protected] to see their PPM or to schedule a call with their CEO.